Athyrium Capital Management
Athyrium Capital Management is a New York-based investment firm founded in 2008 that makes structured investments — royalties, structured credit, equity, and select special situations — in healthcare and life sciences companies globally, including biopharma, pharmaceuticals, medical devices and products, and healthcare services/technology. The firm advises funds with over $4.6 billion of committed capital and can invest up to $200 million per transaction, targeting commercial-stage public and private companies led by industry-leading management teams.
New York, United States · 9+ investments · 8 portfolio companies
- Headquarters
- New York, United States
- Founded
- 2008
- Website
- athyrium.com
- AUM
- $4.6B
- Portfolio Companies
- 8
- Total Investments
- 9
- Last Investment
- Jan 2024
- Geographic Focus
- Global
Investment Thesis
Athyrium Capital Management is a Private Equity firm based in New York, United States. It has made 9 investments, including Agendia, BioCryst Pharmaceuticals and Pharmaceutics International. Focus areas include Healthcare.
Portfolio8
Co-investors24
Sign up to view co-investors
24 co-investors across 25 shared portfolio companies — who they back alongside, and how often they lead.
Venture Capital ×17 · Private Equity ×3 · Growth Equity ×1 · 15 shared rounds
Investment History
Sign up to view investment history
Create a free account with 25 free credits every month, no card needed, to unlock deal history, amounts, and round details.
Your firm? Embed this profile
Add the live badge to your site — it stays current as your portfolio data updates.
<a href="https://indexed.vc/investors/athyrium-capital-management"><img src="https://indexed.vc/api/badge/investor/athyrium-capital-management" alt="Athyrium Capital Management on Indexed.vc" width="260" height="76" /></a>